Chromone-based monoamine oxidase B inhibitor with potential iron-chelating activity for the treatment of Alzheimer’s disease

Chromone-based monoamine oxidase B inhibitor with potential iron-chelating activity for the treatment of Alzheimer’s disease

AbstractBased on the multitarget-directed ligands (MTDLs) strategy, a series of chromone-hydroxypyridinone hybrids were designed, synthesised, and evaluated as potential multimodal anti-AD ligands. Prospective iron-chelating effects and favourable monoamine oxidase B (MAO-B) inhibitory activities we...

Full description

Bibliographic Details
Main Authors:	Changjun Zhang, Yujia Zhang, Yangjing Lv, Jianan Guo, Bianbian Gao, Yi Lu, Anjie Zang, Xi Zhu, Tao Zhou, Yuanyuan Xie
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:	Alzheimer’s disease multitarget-directed ligands MAO-B inhibitor iron-chelating hydroxypyridinones
Online Access:	https://www.tandfonline.com/doi/10.1080/14756366.2022.2134358

Similar Items

Dual-target anti-Alzheimer’s disease agents with both iron ion chelating and monoamine oxidase-B inhibitory activity
by: Zhisheng Mi, et al.
Published: (2019-01-01)

Discovery of benzamide-hydroxypyridinone hybrids as potent multi-targeting agents for the treatment of Alzheimer's disease
by: Xiaoying Jiang, et al.
Published: (2021-01-01)

SYNTHESIS OF N- ACETONITRIL AND N- ETHYLAMINE- 3- HYDROXYPYRIDINONES AS IRON (III) CHELATORS
by: L.A. SAGHAEI
Published: (2000-12-01)

Iron chelating agents for iron overload diseases
by: Guido Crisponi, et al.
Published: (2014-09-01)

Hydroxypyridinone-Based Metal Chelators towards Ecotoxicity: Remediation and Biological Mechanisms
by: M. Amélia Santos, et al.
Published: (2022-03-01)

Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease
by: Dajiang Zou, et al.
Published: (2023-12-01)

Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro
by: Maria del Carmen Parquet, et al.
Published: (2018-08-01)

Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68
by: Ruslan Cusnir, et al.
Published: (2017-01-01)

The Synthesis and Molecular Structure of 1-(3,4-Dihydroxyphenethyl)-3-hydroxy-2-methylpyridin-4(1H)-one Hydrochloride Methanol Solvate
by: Andreas Decken, et al.
Published: (2013-05-01)

Optimizing the Synthetic Route of Chromone-2-carboxylic Acids: A Step forward to Speed-up the Discovery of Chromone-based Multitarget-directed Ligands
by: Fernando Cagide, et al.
Published: (2019-11-01)

Combined treatment of 3-hydroxypyridine-4-one derivatives and green tea extract to induce hepcidin expression in iron-overloaded β-thalassemic mice
by: Supranee Upanan, et al.
Published: (2015-12-01)

Inhibition of monoamine oxidases by benzimidazole chalcone derivatives
by: Athulya Krishna, et al.
Published: (2023-06-01)

Subnanomolar indazole-5-carboxamide inhibitors of monoamine oxidase B (MAO-B) continued: indications of iron binding, experimental evidence for optimised solubility and brain penetration
by: Nikolay T. Tzvetkov, et al.
Published: (2017-01-01)

Chalcones as Potential Ligands for the Treatment of Parkinson’s Disease
by: Ewelina Królicka, et al.
Published: (2022-07-01)

Determination of Monoamine Oxidase Inhibition and Antioxidant Effects of Various Herbal Teas
by: Başak Yüce Dursun
Published: (2017-07-01)

Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
by: Irene Pachón-Angona, et al.
Published: (2019-01-01)

Bifunctional gallium cation chelators
by: A. G. Polivanova, et al.
Published: (2022-06-01)

Design of new reversible and selective inhibitors of monoamine oxidase A and a comparison with drugs already approved
by: A. Reyes-Chaparro, et al.
Published: (2023-03-01)

Synthesis and Biological Evaluation of New Thiosemicarbazone Derivative Schiff Bases as Monoamine Oxidase Inhibitory Agents
by: Betül Kaya Çavuşoğlu, et al.
Published: (2017-12-01)

Dual Targeting Ligands—Histamine H<sub>3</sub> Receptor Ligands with Monoamine Oxidase B Inhibitory Activity—In Vitro and In Vivo Evaluation
by: Dorota Łażewska, et al.
Published: (2022-10-01)

Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs
by: Rona R. Ramsay, et al.
Published: (2017-07-01)

Monoamine oxidases contribute to endothelial dysfunction of the vascular access in hemodialysis patients
by: Diana Utu, et al.
Published: (2016-12-01)

Synthesis and evaluation of antioxidant activity of some novel hydroxypyridinone derivatives: a DFT approach for explanation of their radical scavenging activity
by: Afshin Fassihi, et al.
Published: (2020-01-01)

A nickel(II) complex with an unsymmetrical tetradentate chelating ligand derived from pyridine-2,6-dicarbaldehyde and 2-aminothiophenol
by: Firas Khalil Al-Zeidaneen, et al.
Published: (2023-09-01)

Inhibitory effects of agmatine on monoamine oxidase (MAO) activity: Reconciling the discrepancies
by: Mancinelli Loretta, et al.
Published: (2018-04-01)

Yeni şalkon türevlerinin monoamin oksidaz enzim inhibitör aktivitelerinin araştırılması
by: Nafiz Öncü CAN
Published: (2018-06-01)

Monoamine oxidase inhibition in cigarette smokers: From preclinical studies to tobacco product regulation
by: Alan F. Sved, et al.
Published: (2022-08-01)

β-Carboline Alkaloids in Soy Sauce and Inhibition of Monoamine Oxidase (MAO)
by: Tomás Herraiz
Published: (2023-03-01)

Potential Roles of microRNAs in the Regulation of Monoamine Oxidase A in the Brain
by: Yuki Higuchi, et al.
Published: (2018-09-01)

Synthesis and Spectral Studies on Heteroleptic Chelated Copper (II) Complexes of Diamine and Acetylacetonate
by: Hamid Golchoubian, et al.
Published: (2012-01-01)

Synthesis and antileishmanial activity of antimony (V) complexes of hydroxypyranone and hydroxypyridinone ligands
by: Vafa Sheikhmoradi, et al.
Published: (2018-01-01)

Development and Clinical Application of Positron Emission Tomography Imaging Agents for Monoamine Oxidase B
by: Jeffrey H. Meyer, et al.
Published: (2022-02-01)

STUDY MOLECULES DOCKING OF ALKALOIDS IN KRATOM ON SEROTONIN TRANSPORTER (SERT), NOREPINEPHRINE TRANSPORTER (NET), AND MONOAMINE OXIDASE (MAO)
by: Dandi Irawan, et al.
Published: (2023-12-01)

Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disease
by: Pablo Duarte, et al.
Published: (2022-01-01)

Quinoline-Malononitrile-Based Aggregation-Induced Emission Probe for Monoamine Oxidase Detection in Living Cells
by: Chuthamat Duangkamol, et al.
Published: (2023-03-01)

Replacement of Chalcone-Ethers with Chalcone-Thioethers as Potent and Highly Selective Monoamine Oxidase-B Inhibitors and Their Protein-Ligand Interactions
by: Bijo Mathew, et al.
Published: (2021-11-01)

Synthesis and Monoamine Oxidase Inhibition Properties of 4-(2-Methyloxazol-4-yl)benzenesulfonamide
by: Anton A. Shetnev, et al.
Published: (2024-03-01)

Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca
by: Ilana Berlowitz, et al.
Published: (2022-05-01)

Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer’s disease
by: Zhipei Sang, et al.
Published: (2022-01-01)

Chelating Agent Functionalized Substrates for the Formation of Thick Films via Electrophoretic Deposition
by: Sara C. Mills, et al.
Published: (2021-06-01)